Dabur India Limited · NSE:DABUR
Dabur India — Q3 FY23 Earnings Presentation
28 slides from Dabur India's earnings presentation, Feb 2, 2023
Slide 1: Exchange filing cover letter: Investor Communication
^^. »i^iV^^. ^p?- f> x Ref:SEC/SE/2022-23 fur Date:February 2,2023 India ltd. To, Corporate Relation Department National Stock Exchange of India Ltd. BSE Ltd. Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/l, G Block, Bandra Kurla Complex Dalal Street, Mumbai- 400001 Bandra (E), Mumb
Slide 2: Q3 FY23 Results Presentation
” pm Chyawanprash f ) ‘ 4 SA Chyawanprash Q3 FY23 — RESULTS PRESENTATION 2ND FEBRUARY 2023
Slide 3: Q3 FY23 & 9M FY23: Performance Summary
1. Q3 FY23 & 9M FY23: Performance Summary 2. Business Highlights 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 2
Slide 4: Q3 FY23 & 9M FY23: Performance Summary
1. Q3 FY23 & 9M FY23: Performance Summary 2. Business Highlights 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 3
Slide 5: Revenue, Operating Profit, PAT (Q3)
Revenue Operating Profit PAT 3-year CAGR: 9.0% 3-year CAGR: 7.4% 3-year CAGR: 6.2% 3,043 21.3% 17.1% 20.0% 2,942 15.6% 503 628 610 476 3.4%* (2.8%) (5.4%) 5.7%** Q3 FY22 Q3 FY23 Q3 FY22 Q3 FY23 Q3 FY22 Q3 FY23 *INR growth Operating Profit (INR cr) **CC growth PAT (INR cr) PAT Margin Operating Margin
Slide 6: Sales Contribution by Verticals
Sales Contribution by Verticals Q3 FY22 Q3 FY23 Healthcare Home & Personal Care (HPC) Food & Beverage (F&B) 3-year CAGR: 8.4% 3-year CAGR: 8.7% 3-year CAGR: 15.2% 864.8 835.1 858.0 319 965 986 300 890 673.0 768 209 218 28% (3%) 3% 16% 8% 2.2% 4% 38% 6.4% Q3 FY20 Q3 FY21 Q3 FY22 Q3 FY23 Q3 FY20 Q3 FY
Slide 7: Sales Contribution and International Growth
Q3 FY22 Sales Contribution Q3 FY23 Sales Contribution Others Others 3.0% 3.0% International International 25.1% 25.5% Domestic Domestic 71.9% 71.5% International Business grew by 14% in CC terms (5.1% in INR terms) Q3 FY23 Constant Currency Growth % 97.0% 35.0% 16.7% 8.0% (10.1%) (0.7%) MENA Egypt S
Slide 8: Revenue, Operating Profit, PAT (9M)
Revenue Operating Profit PAT 3-year CAGR: 9.0% 3-year CAGR: 6.8% 3-year CAGR: 6.5% 17.3% 8,852 15.9% 8,371 21.5% 19.8% 1,445 1,406 1,800 1,754 5.7%* (2.6%) (2.7%) 8.1%** 9M FY22 9M FY23 9M FY22 9M FY23 9M FY22 9M FY23 *INR growth Operating Profit (INR cr) **CC growth PAT (INR cr) PAT Margin Operatin
Slide 9: Business Highlights
1. Q3 FY23 & 9M FY23: Performance Summary 2. Business Highlights 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 8
Slide 10: Health Supplements, Digestives, OTC & Ethicals
Health Supplements Digestives OTC & Ethicals Growth % 0.4% 11.2% 4.0% 3-year CAGR 7.5% 7.5% 11.4% • Health Supplements return to • The portfolio saw strong growth • Driven by strong growth of OTC portfolio and ex-Covid positive growth trajectory after on a high base of 12.2% growth contextual Ethica
Slide 11: Click on the image to play
Click on the image to play 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 10
Slide 12: Click on the image to play
Click on the image to play 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 11
Slide 13: Click on the image to play
Click on the image to play 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 12
Slide 14: Click on the image to play
Click on the image to play 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 13
Slide 15: NPD - Healthcare
Gokshura a: & Bone & Joint Welln 7 strengthens Bones Tens Wellness ane ee : Nita Improves Vigour & Vitality Improves Physical Endurance’ Gokshura Men's Wellness Improves Vigour Vitality Ineores Pha STRONG BON 1 TO MEN'S WELLNESS. PROMOTES VIGOUR & VITALITY. AYURVEDIC MEDICINE
Slide 16: NPD - Healthcare
2X: Strength, Stamina & Energy“ Now Available as Sugar Free be a is i BUY NOW i Mot 28 Str Keeps You & Stamina Helps Reduce Stress Energetic & Active ‘vs baseline after regular consumption in cSinical study.
Slide 17: NPD - Healthcare
NPD - Healthcare ZT Sarpagandhaghan Vati Ayurved Sar Sangraha/Gutika Vati Prakaran Promotes Healthy Sleep Pattern and helps relieve Stress & Anxiety
Slide 18: NPD - Healthcare
rm anWa Kas A a STRENGTH, STAMINA
Slide 19: Home Care, Oral Care, Hair Oils, Shampoo, Skin & Salon
Home Care Oral Care Hair Oils Shampoo Skin & Salon Growth % 18.2% 2.6% (2.4%) 3.6% (5.6%) 3-year CAGR 11.5% 11.9% 4.9% 16.9% 2.1% • Robust double-digit • Toothpaste portfolio • Hair oils portfolio • Shampoos portfolio • Delayed winter growth for Odonil, recorded 3.2% recorded 2.4% posted 3.6% growth
Slide 20: Click on the image to play
Click on the image to play 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 19
Slide 21: Click on the image to play
Click on the image to play 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 20
Slide 22: Click on the image to play
Click on the image to play 02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 21
Slide 23: Beverages and Foods
Beverages Foods Growth % 3.7% 34.5% 3-year CAGR 14.3% 24.3% • Beverage business continued to be on a strong trajectory • Hommade brand continued to perform well driven by despite being impacted by early onset of the festive season innovation and portfolio expansion Category Highlights • Outperformed
Slide 24: NPD - Food & Beverages
NPD - Food & Beverages today journey in your
Slide 25: DABUR – Q3 FY23 - RESULTS PRESENTATIO N
02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 24
Slide 26: Consolidated P&L
Q3 FY23 Q3 FY22 Y-o-Y (%) 9M FY23 9M FY22 Y-o-Y (%) Revenue from operations 3,043.2 2,941.8 3.4% 8,852.1 8,370.9 5.7% Other Income 100.8 96.7 4.2% 324.7 294.0 10.4% Total Income 3,144.0 3,038.5 3.5% 9,176.8 8,664.9 5.9% Material Cost 1,658.2 1,519.6 9.1% 4,817.6 4,316.4 11.6% % of Revenue 54.5% 51.7
Slide 27: India Standalone P&L
Q3 FY23 Q3 FY22 Y-o-Y (%) 9M FY23 9M FY22 Y-o-Y (%) Revenue from operations 2,298.3 2,224.4 3.3% 6,744.9 6,327.2 6.6% Other Income 85.6 81.1 5.7% 277.4 249.4 11.2% Total Income 2,383.9 2,305.5 3.4% 7,022.3 6,576.5 6.8% Material Cost 1,267.3 1,184.1 7.0% 3,773.4 3,357.9 12.4% % of Revenue 55.1% 53.2%
Slide 28: DABUR – Q3 FY23 - RESULTS PRESENTATIO N
02/02/2023 DABUR – Q3 FY23 - RESULTS PRESENTATIO N 27